About GT MOLECULAR, INC.
GT Molecular develops high-performance digital PCR and NGS kits for wastewater, cancer research, and pathogen detection. The company provides rapid testing services for SARS-CoV-2, Influenza, mpox, and other pathogens.
High-performance digital PCR and NGS kits for wastewater, cancer research, and pathogen detectionUltra-sensitive pathogen PCR tests for detecting nucleic acid fragments in wastewater samplesNext-generation sequencing services for microbial community analysis and pathogen variant characterizationCustom dPCR, qPCR, and NGS assays for cancer genotyping and waterborne pathogen detectionWastewater surveillance testing for SARS-CoV-2, Influenza A/B, RSV, Mpox, illicit drugs, and other pathogens
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NWSS MULTI-ASSAY PANEL DEVELOPMENT | Department of Health and Human Services | $297K | |
| NATIONAL WASTEWATER SURVEILLANCE SYSTEM MULTI-PATHOGEN ASSAY DEVELOPMENT, OPTIMIZATION, VALIDATION, AND SUPPOR | Department of Health and Human Services | $1.0M |
Teaming History
Prime contractors GT MOLECULAR, INC. has worked under:
- Eastern Research Group, Inc. — 1 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GT MOLECULAR, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.